EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Risk factors for recurrent stenosis after balloon dilation for benign hepaticojejunostomy anastomotic stricture

Takafumi Mie, Takashi Sasaki, Takeshi Okamoto, Tsuyoshi Takeda, Chinatsu Mori, Yuto Yamada, Takaaki Furukawa, Akiyoshi Kasuga, Masato Matsuyama, Masato Ozaka, Naoki Sasahira

Clinical Endoscopy · 30.03.2024 · 57 (2) · 253-262

DOI: 10.5946/ce.2022.216 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endoscopy, erschienen am 30.03.2024. Verfasst von Takafumi Mie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Hepaticojejunostomy anastomotic stricture (HJAS) is a feared adverse event associated with hepatopancreatobiliary surgery. Although balloon dilation for benign HJAS during endoscopic retrograde cholangiopancreatography with balloon-assisted enteroscopy has been reported to be useful, the treatment strategy remains controversial. Therefore, we evaluated the outcomes and risk factors of recurrent stenosis after balloon dilation alone for benign HJAS.

Methods

We retrospectively analyzed consecutive patients who underwent balloon-assisted enteroscopy–endoscopic retrograde cholangiopancreatography for benign HJAS at our institution between July 2014 and December 2020.

Results

Forty-six patients were included, 16 of whom had recurrent HJAS after balloon dilation. The patency rates at 1 and 2 years after balloon dilation were 76.8% and 64.2%, respectively. Presence of a residual balloon notch during balloon dilation was an independent predictor of recurrence (hazard ratio, 2.80; 95% confidence interval, 1.01–7.78; p=0.048), whereas HJAS within postoperative 1 year tended to be associated with recurrence (hazard ratio, 2.43; 95% confidence interval, 0.85–6.89; p=0.096). The patency rates in patients without a residual balloon notch were 82.1% and 73.1% after 1 and 2 years, respectively.

Conclusions

Balloon dilation alone may be a viable option for patients with benign HJAS without residual balloon notches on fluoroscopy.

Schlagwörter

Stichwörter der Autor:innen

Adverse eventsBalloon dilationBalloon-assisted enteroscopyEndoscopic retrograde cholangiopancreatographyHepaticojejunostomy anastomotic stricture

Autor:innen und Institutionen

  • Department of Hepato-Biliary-Pancreatic Medicine, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Zitieren

APA

Mie, T., Sasaki, T., Okamoto, T., Takeda, T., Mori, C., Yamada, Y., Furukawa, T., Kasuga, A., Matsuyama, M., Ozaka, M., & Sasahira, N. (2024). Risk factors for recurrent stenosis after balloon dilation for benign hepaticojejunostomy anastomotic stricture. Clinical Endoscopy, 57(2), 253-262. https://doi.org/10.5946/ce.2022.216

Vancouver

Mie T, Sasaki T, Okamoto T, Takeda T, Mori C, Yamada Y, et al. Risk factors for recurrent stenosis after balloon dilation for benign hepaticojejunostomy anastomotic stricture. Clinical Endoscopy. 2024;57(2):253-262. doi:10.5946/ce.2022.216

BibTeX
@article{Mie2024,
  author = {Mie, Takafumi and Sasaki, Takashi and Okamoto, Takeshi and Takeda, Tsuyoshi and Mori, Chinatsu and Yamada, Yuto and Furukawa, Takaaki and Kasuga, Akiyoshi and Matsuyama, Masato and Ozaka, Masato and Sasahira, Naoki},
  title = {Risk factors for recurrent stenosis after balloon dilation for benign hepaticojejunostomy anastomotic stricture},
  journal = {Clinical Endoscopy},
  year = {2024},
  volume = {57},
  number = {2},
  pages = {253--262},
  doi = {10.5946/ce.2022.216}
}
Kostenlos starten →